Nippon Life Global Investors Americas, Inc. Abb Vie Inc. Transaction History

Nippon Life Global Investors Americas, Inc.

$2.22 Billion
Q2 2024

A detailed history of Nippon Life Global Investors Americas, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Nippon Life Global Investors Americas, Inc. holds 59,360 shares of ABBV stock, worth $10.1 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

59,360

Previous 53,460 11.04%

Holding current value

$10.1 Million

Previous $9.74 Million 4.58%

% of portfolio

0.46%

Previous 0.47%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $913,261 - $1.07 Million	5,900 Added 11.04%	59,360 $10.2 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1.41 Million - $1.61 Million	8,840 Added 19.81%	53,460 $9.74 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $130,918 - $151,557	-980 Reduced 2.15%	44,620 $6.65 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $2.83 Million - $3.52 Million	-21,320 Reduced 31.86%	45,600 $6.14 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $1.36 Million - $1.56 Million	-9,380 Reduced 12.29%	66,920 $10.7 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $1.18 Million - $1.42 Million	-8,540 Reduced 10.07%	76,300 $12.3 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1.91 Million - $2.19 Million	-14,250 Reduced 14.38%	84,840 $11.4 Million
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $909,668 - $1.16 Million	6,610 Added 7.15%	99,090 $15.2 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $1.26 Million - $1.57 Million	-9,570 Reduced 9.38%	92,480 $15 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $763,827 - $966,462	7,110 Added 7.49%	102,050 $13.8 Million
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $2.79 Million - $3.17 Million	-26,230 Reduced 21.65%	94,940 $10.2 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $3.77 Million - $4.16 Million	36,900 Added 43.79%	121,170 $13.1 Million
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $6.78 Million - $9.16 Million	84,270 New	84,270 $9.03 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $4.36 Million - $6.62 Million	-67,660 Closed	0 $0
Q3 2019 Oct 21, 2019	BUY	$62.98 - $75.72 $4.26 Million - $5.12 Million	67,660 New	67,660 $5.12 Million
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $4.13 Million - $5.27 Million	-62,800 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $370,272 - $435,792	-4,800 Reduced 7.1%	62,800 $5.06 Million
Q3 2018 Oct 31, 2018	BUY	$88.91 - $98.84 $253,393 - $281,694	2,850 Added 4.4%	67,600 $6.39 Million
Q2 2018 Jul 18, 2018	BUY	$89.78 - $106.23 $5.81 Million - $6.88 Million	64,750 New	64,750 $6 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.

Account

Nippon Life Global Investors Americas, Inc. Abb Vie Inc. Transaction History